CERE Market Cap History Table | ||||||||||||||||||
Also see: CERE Shares Outstanding History and CERE YTD Return |
CERE Market Cap History Table | ||||||||||||||||||
Also see: CERE Shares Outstanding History and CERE YTD Return |
CERE Market Cap History Chart | ||||||||||||||||||||||||
+48.38% CAGR Mouse over chart for data details
|
CERE Stock Price Chart |
About Cerevel Therapeutics Holdings Inc |
Cerevel Therapeutics Holdings is a clinical-stage biopharmaceutical company. Co.'s programs: Emraclidine is a positive allosteric modulator (PAM), that selectively targets the muscarinic acetylcholine 4 receptor subtype; Darigabat, which is a PAM that selectively targets the alpha-2/3/5 subunits of the GABAA receptor; Tavapadon, which is a selective dopamine D1/D5 receptor partial agonist that it is developing for the treatment of early- and late-stage Parkinson's disease; and CVL-871, which is a selective dopamine D1/D5 receptor partial agonist specifically designed to achieve a level of partial agonism. We show 8 historical shares outstanding datapoints in our CERE shares outstanding history coverage, used to compute CERE market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing CERE market cap history over the course of time is important for investors interested in comparing CERE's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of CERE versus a peer is one thing; comparing CERE market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like CERE can fluctuate over the course of history. With this page we aim to empower investors researching CERE by allowing them to research the CERE market cap history. |
CERE Current Stock Quote |
Free CERE Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: The Importance of Market Cap | |
|
CERE Share Performance |
Market Cap Peers |
Cerevel Therapeutics Holdings (CERE) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
CERS Market Cap History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.